Annual Total Liabilities
$5.65 M
-$214.33 M-97.43%
December 31, 2023
Summary
- As of February 22, 2025, SGMT annual total liabilities is $5.65 million, with the most recent change of -$214.33 million (-97.43%) on December 31, 2023.
- During the last 3 years, SGMT annual total liabilities has fallen by -$199.22 million (-97.24%).
- SGMT annual total liabilities is now -97.43% below its all-time high of $219.98 million, reached on December 31, 2022.
Performance
SGMT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.09 M
-$1.64 M-28.56%
September 30, 2024
Summary
- As of February 22, 2025, SGMT quarterly total liabilities is $4.09 million, with the most recent change of -$1.64 million (-28.56%) on September 30, 2024.
- Over the past year, SGMT quarterly total liabilities has dropped by -$1.56 million (-27.63%).
- SGMT quarterly total liabilities is now -98.14% below its all-time high of $219.98 million, reached on December 31, 2022.
Performance
SGMT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SGMT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.4% | -27.6% |
| 3 y3 years | -97.2% | -98.1% |
| 5 y5 years | -95.9% | -98.1% |
SGMT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.4% | at low | -98.1% | at low |
| 5 y | 5-year | -97.4% | at low | -98.1% | at low |
| alltime | all time | -97.4% | at low | -98.1% | at low |
Sagimet Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.09 M(-28.6%) |
| Jun 2024 | - | $5.73 M(+27.0%) |
| Mar 2024 | - | $4.51 M(-20.2%) |
| Dec 2023 | $5.65 M | $5.65 M(+12.0%) |
| Sep 2023 | - | $5.05 M(-97.7%) |
| Jun 2023 | - | $219.91 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $219.95 M(-0.0%) |
| Dec 2022 | $219.98 M(+1.2%) | $219.98 M(+1.0%) |
| Dec 2021 | $217.29 M(+6.1%) | - |
| Mar 2021 | - | $217.78 M |
| Dec 2020 | $204.87 M(+50.1%) | - |
| Dec 2019 | $136.47 M | - |
FAQ
- What is Sagimet Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Sagimet Biosciences?
- What is Sagimet Biosciences annual total liabilities year-on-year change?
- What is Sagimet Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sagimet Biosciences?
- What is Sagimet Biosciences quarterly total liabilities year-on-year change?
What is Sagimet Biosciences annual total liabilities?
The current annual total liabilities of SGMT is $5.65 M
What is the all time high annual total liabilities for Sagimet Biosciences?
Sagimet Biosciences all-time high annual total liabilities is $219.98 M
What is Sagimet Biosciences annual total liabilities year-on-year change?
Over the past year, SGMT annual total liabilities has changed by -$214.33 M (-97.43%)
What is Sagimet Biosciences quarterly total liabilities?
The current quarterly total liabilities of SGMT is $4.09 M
What is the all time high quarterly total liabilities for Sagimet Biosciences?
Sagimet Biosciences all-time high quarterly total liabilities is $219.98 M
What is Sagimet Biosciences quarterly total liabilities year-on-year change?
Over the past year, SGMT quarterly total liabilities has changed by -$1.56 M (-27.63%)